NPI: 1215997416 · CAMBRIDGE, MD 21613 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 03/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,819 | $12K |
| 2019 | 11,773 | $53K |
| 2020 | 8,449 | $113K |
| 2021 | 9,356 | $132K |
| 2022 | 3,316 | $79K |
| 2023 | 1,807 | $46K |
| 2024 | 739 | $28K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 11,104 | 1,123 | $378K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,473 | 1,037 | $52K |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,039 | 868 | $15K |
| J1756 | Injection, iron sucrose, 1 mg | 2,188 | 626 | $8K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 15 | 12 | $4K |
| 83970 | 742 | 640 | $3K | |
| A4657 | Syringe, with or without needle, each | 1,947 | 1,268 | $920.57 |
| 82728 | 501 | 439 | $1.74 | |
| 83550 | 545 | 462 | $1.12 | |
| 83540 | 545 | 462 | $0.83 | |
| 85041 | 999 | 861 | $0.38 | |
| 85048 | 999 | 860 | $0.32 | |
| 82947 | 27 | 26 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 121 | 67 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 14 | 12 | $0.00 |